SUDA Pharmaceuticals Ltd. announced that MTPK cited challenges with their regulatory body, the Ministry of Food and Drug Safety (MFDS). SUDA has agreed to terminate the Agreement and the Company notes that there is no immediate financial impact as a result of the termination. SUDA will continue to focus on its partnership with TEVA, and look to secure additional partners for the ASEAN region and other territories.